Skip to main content

Table 8 Annotation of genes with Class A mutation or CNAs in MDA sub-lines

From: The stepwise evolution of the exome during acquisition of docetaxel resistance in breast cancer cells

MDA MDA MDA MDA MDA
SUB-0.27nM SUB-5nM SUB-15nM SUB-100nM RES-150nM
  Chromatin modification Nucleotide-binding   Protein dimerization activity
MSL3, KDM6A, PHF16, KDM4C, RBBP7 ABCB1, JAK2, RIOK1, CDK16, CDK14, PRKX NOTCH2, VWF, SLC11A1, DPP4
Purine nucleoside binding, adenyl nucleotide binding, atp-binding T cell activation
EPHA5, RPS6KA3, ABCA9, DDX3X, UBA1, MAPK13, CASK, CTPS2, VARS, PRPS2, CLCN4 CARD11, SLC11A1, DPP4
Kinase Transport
EPHA5, RPS6KA3, MAPK13, SH3KBP1, CASK, PRPS2 SLC11A1, CACNA1I, MFI2, CACNA2D3, AQP7, AQP3
Regulation of transcription from RNA polymerase II promoter
CASK, MED14, RBBP7, TBL1X
Transport
CLCN4, CCDC64, AP1S2, CASK, ABCA9, ATP5J, APOO